NEW YORK (GenomeWeb News) – Febit said today that it will collaborate with the Translational Genomics Research Institute to evaluate the use of Febit’s Geniom microarray technology in capturing DNA for next-generation sequencers.
 
TGen is Febit’s first US pilot user for the HybSelect technology, which the company said enables selective DNA capture and elution in order to pre-select sequences for next-generation platforms.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.